Table 1:
Tissue | Cell type or cell line | Physiological or cellular function | Reference |
---|---|---|---|
Intestinal | L-cells | Secretion of GLP-1 | [6] |
L-cells | Inhibition of GLP-2 secretion | [20] | |
K-cells | Secretion of GIP | [7], [25, 27] | |
Murine STC1, GLUTag | Secretion of GLP-1 | [26] | |
HCT116, HT-29, Caco-2 human colon epithelial cancer cells | Increase cytosolic Ca+2 Increase phosphorylation of ERK1/2 | [31] | |
Gastric | Ghrelin secreting | Inhibition of ghrelin secretion | [33–35] |
Tongue | Circumvallate papillae epithelia | Fat sensing, GLP-1 secretion | [40–42] |
Type II taste cells | Taste perception | [40–42] | |
Adipose | SQ, PR, Mes, Epi fat 3T3-L1 cells |
Adipocyte differentiation, GLUT4 translocation, glucose uptake VEGF-A induced angiogenesis |
[45–47], [52] |
M2 and M1 macrophages, | Anti-inflammatory effects, insulin sensitization | [49–51] | |
Macrophages | M2 and M1 macrophages, murine Raw264.7 cells, human THP-1 cells | Anti-inflammatory effects, reduced inflammasome assembly and activity, insulin sensitization | [49], [53–55] |
Pancreatic Islets | Islet cells | Protection from lipotoxicity | [56] |
Human and mouse α-cells | Glucagon synthesis and secretion Downstream hepatic glucagon sensitivity |
[18], [57] | |
Mouse delta-cells | Inhibition of somatostatin secretion | [18] | |
Murine αTC1–6 cells | [58] | ||
Skeletal Muscle | Rat and murine gastrocnemius and soleus skeletal muscle | Reduced inflammation, improved insulin sensitivity | [51], [59] |
Rat L6 and murine C2C12 myoblasts | GLUT4 translocation and increased glucose uptake | [60] | |
Liver | Murine macrophage-like Kupffer cells | Reduced inflammation | [62] |
Human hepatocytes, hepatic stem/progenitor cells, and hepatic Kupffer cells | Reduced inflammation, macrophage polarization | [63] | |
Rat liver WB-F344 cells | Cell migration | [66] | |
Bone | Osteoclasts | Reduced inflammation, inhibition of osteoclast development and bone resorption | [70–72] |
Murine ST2 and MC3T3-E1 preosteoblasts | [70] |